Demand for Anesthesia CO2 Absorbent and Impact of COVID-19……..



Global Anesthesia CO2 Absorbent Market is expected to reach USD 79.1 million by 2022, according to a new report by Grand View Research, Inc. Rising geriatric population, increasing usage of regional anesthesia, and augmenting volume of surgical procedures across the globe are vital impact rendering drivers for the market.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

Anesthesia CO2 absorbent forms a niche segment within the anesthesia disposables, the demand for which is expected to rise with increasing number of surgeries. According to the statistics provided by the WHO in collaboration with the Department of Health Policy and Management of Harvard, the global surgical volume is high and accounts for about 234 million surgeries per year.
Furthermore, with this increase, a proportional rise in complications and deaths after surgery are being witnessed. According to the statistics provided by the U.S. Agency for Healthcare Research and Quality, one in 150 patients dies due to improper administration of anesthesia.
The Harvard School of Public Health’s study links economic conditions of a country with volume of surgeries and states that prevalence of major surgeries is 37 times higher in countries with healthcare expenditure above USD 1,000 per person.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·         Amsorb is expected to witness the fastest growth over the forecast period owing to increasing demand for absorbents free from presence of KOH and clarity in exhaustion indication. Amsorb is anticipated to grow at a CAGR of over 10.0% over the next seven years and contribute about 14.0% revenue to the industry.
·         Latin America and Asia Pacific are predicted to be the fastest growing regions for the anesthesia CO2 absorbent market. Together, they are expected to hold over 25.0% of the market share by 2022. Strategic reforms in healthcare policies and increasing healthcare spending patterns are expected to be the market drivers within the region.
·         Key players of the industry include GE Healthcare, Smiths Medical, CareFusion (Becton Dickinson and Co.), Armstrong Medical, and Drager Medical GmbH. Other players include King Pharmaceuticals, Allied Healthcare Products, Molecular Products, Micropore, and Medisize. GE Healthcare’s vital sign division responsible for manufacturing of anesthesia COabsorbent was acquired by CareFusion in 2013, thereby making it a leader for single patient use consumables for anesthesiology.
·         Also, cases of patent infringement are being reported by players such as Drager. In October 2015, the company filed a patent infringement lawsuit against Allied Healthcare alleging infringement carbolyme single use carbon dioxide absorption cartridges. This action is anticipated to help the company maintain its market share and control competition.
The global Anesthesia CO2 Absorbent Market size was valued at USD 43.7 million in 2015 and is expected to grow at a CAGR of 8.8% over the next seven years. Some key drivers includethe rising incidences of chronic illnesses and fatal accidents, augmentinggeriatric population, and increasing volume of surgeries.
Increasing incidences of chronic conditionsare expected to increase demand for surgeries. With rising volume of surgeries, required anesthesia is anticipated to rise, thereby propelling market growth. Furthermore, guidelines and safety parameters decided by institutes such as the Anesthesia Patient Safety Foundation, the CEA, and the CDC are other vital impact rendering drivers.
A huge geriatric population base is prone to suffer from diseases such as cardiac disorders, neurological conditions, respiratory diseases, and diabetes, ultimately demanding surgical intervention. This acts as a major driver for growth.
According to the WHO, about 7.6% of the population suffers from respiratory diseases globally.Prevalence of respiratory diseases increases with age and would affectover 15.0% for geriatric population.
Supportive government initiatives for healthcare are expected to positively impact growth of anesthesia disposables and thereby the anesthesia CO2 absorbent market.For instance, it intends to expand its infrastructure to grassroots medical networks through investments in hospitals.
In February 2015, the European Investment Bank announced a grant of USD 150.9 million for construction of the Midland Metropolitan Hospital in England. This hospital is expected to specialize in accident and trauma casesand form the largest emergency department of the country.
Have any Query? Ask our Experts:
Grand View Research has segmented the global Anesthesia CO2 Absorbent Market on the basis of products: 
Global Anesthesia COAbsorbent Product Outlook (Revenue, USD Million, 2012 - 2022)
·         Soda lime
·         Medisorb
·         Dragersorb
·         Amsorb
·         Litholyme
·         Others
The key products analyzed in the study are Soda lime, Medisorb, Dragersorb, Amsorb, Litholyme, and others.The brands, Medisorb, Dragersorb, and Amsorb are currently capturing majority of the market share. However, over the next seven years, newer formulations such as SpiraLith are anticipated to change the dynamics.
Medisorb is expected to dominate the market in 2015 with over 25% share owing to the company’s efficient distribution network and goodwill. Amsorb plus from the Amsorb segment is the latest product offered by the manufacturer and is documented to eliminate formation of toxic products such as compound A and carbon monoxide. Hence, it is expected to witness the fastest growth over the forecast period.
Continuous evolution of absorbent formulations to enhance product performance is expected to propel demand over the next seven years. Manufacturers are primarily focusing on preventing the formation of fatal compounds and increasing the absorption capacity during the anesthesia process.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.




Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..